354 results on '"Kondo, Nobuyuki"'
Search Results
52. Abstract 4478: Effective prediction of treatment responders with anti-PD-1 antibody in malignant pleural mesothelioma by diversity of peripheral CD8+PD-1+ T cell subpopulation
53. Tumor‐associated macrophage‐derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma
54. Right Lower Lobectomy for an Aberrant Mediastinal Inferior Lobar Artery
55. Initial evaluation of nivolumab in patients with post-operative recurrence of malignant pleural mesothelioma
56. Clinical Outcomes With Recurrence After Pleurectomy/Decortication for Malignant Pleural Mesothelioma
57. Non-incisional pleurectomy/decortication
58. Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma
59. Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma – Comparison with contrast-enhanced CT
60. The mTOR Signaling Pathway Is Associated With the Prognosis of Malignant Pleural Mesothelioma After Multimodality Therapy
61. Sternal wound dehiscence after transverse thoracosternotomy for bilateral lung transplantation: Report of a case
62. Thrombin induces rapid disassembly of claudin-5 from the tight junction of endothelial cells
63. High level of endothelial cell-specific gene expression by a combination of the 5′ flanking region and the 5′ half of the first intron of the VE-cadherin gene
64. Current Status and Perspective on Surgical Treatment of Lung Cancer: S-6-2
65. Modulation of VEGFR-2–mediated endothelial-cell activity by VEGF-C/VEGFR-3
66. Thermal decomposition products of the heteronuclear complex, LaNi(dhbaen)(NO 3)(H 2O) n
67. Abstract 2230: Diversity of peripheral CD8+PD-1+ T cells is a novel predictive biomarker for response to anti-PD-1 antibody treatment in lung cancer patients
68. Correlation between peripheral CD8+PD-1+ T cells diversity, tumor mutation burden (TMB) and T cell clones with anti-PD-1 antibody treatment of lung cancer patients: TCR repertoire as a novel predictive biomarker.
69. Outcome of neo-adjuvant chemotherapy in 225 surgical candidates with malignant pleural mesothelioma.
70. Survival impact of thoracic cavity reduction during neoadjuvant chemotherapy in patients undergoing surgery for malignant pleural mesothelioma.
71. Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma
72. A rare case of pleomorphic adenoma with difficult diagnosis using biopsy
73. Radiofrequency Ablation Effectively Treated Focal Recurrence of Mesothelioma
74. The clinical value of circulating tumour cells (CTCs) in patients undergoing pulmonary metastasectomy for metastatic colorectal cancer
75. Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer
76. Methadone for management of persistent pain after extrapleural pneumonectomy
77. 大腸癌腎転移の1例
78. Lung metastases in an atypical type A thymoma variant
79. Abstract 5191: A combination of Stat3 inhibitor and radiation for the treatment of malignant pleural mesothelioma
80. Influence of a STAT3 inhibitor on tumor infiltrating lymphocytes in malignant pleural mesothelioma.
81. Circulating Tumor Cell Count Can Be a Useful Prognostic Factor in Lung Resection via Cardiopulmonary Bypass
82. Testicular microlithiasis: report of 14 cases
83. Abstract 2488: Stat3 inhibitor (BBI-608) with radiation therapy is promising in malignant pleural mesothelioma
84. The significance of RB expression in malignant pleural mesothelioma in multidisciplinary treatment including extrapleural pneumonectomy.
85. A case of pulmonary metastasis from poorly differentiated thyroid carcinoma 43 years after thyroidectomy
86. Early Malignant Pleural Mesothelioma Without Macroscopic Findings in the Parietal Pleura: a Case Report
87. Analysis of critical situations in thoracic surgery
88. A Multicenter Feasibility Study of EBUS-TBNA for Potentially Operable Non-Small Cell Lung Cancer: The JMTO LC07-02 Study (UMIN000001280)
89. Prospective, multicenter study of pleural adhesion in repeated pulmonary surgery
90. Spontaneous rupture of renal angiomyolipoma : a case report
91. Oncocytoma associated with acquired cystic disease of kidney (ACDK) : a case report
92. Abstract 2581: Antitumor effect of Trametinib, a selective MEK inhibitor, in combination with 4-methylumbelliferone, a hyaluronic acid synthesis inhibitor, in Malignant pleural mesothelioma cell lines
93. Gene Mutation Analysis in Determining Late Recurrence of Adenocarcinoma of the Lung
94. Circulating tumor cell (CTC) as a prognostic marker in primary lung cancer.
95. ERCC1 in patients with Malignant Pleural Mesothelioma (MPM) treated by neoadjuvant chemotherapy followed by extrapleural pneumonectomy (EPP).
96. Determining association between activation of mTOR signal pathway and patient with malignant pleural mesothelioma who underwent a multimodality therapy including extrapleural pneumonectomy.
97. トロンビンにより血管内皮細胞のタイトジャンクションからクローディン-5の急速な消失が誘導される
98. MICS position is safe and effective in thoracoscopic surgery for anterior mediastinum tumor
99. Abstract 742: Antitumor activity of Trametinib, a MEK1/2 inhibitor, in malignant pleural mesothelioma cells in vitro
100. Clinical evaluation of the combination of carumonam and cefotiam in the treatment of complicated urinary tract infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.